Panel Discussion – How Can We Build a More Comprehensive Understanding of Drug Safety Through Improved Preclinical Models?

Time: 11:30 am
day: Track B - Day 2

Details:

  •  What weaknesses exist with current models?
  • How can the role of the immune system best be understood preclinically?
  • Comparing and contrasting syngeneic and xenograft models